Literature DB >> 1758809

Specific lipid lowering therapy in the management of diabetes.

P N Durrington1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1758809      PMCID: PMC2399159          DOI: 10.1136/pgmj.67.792.947

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  33 in total

1.  Effects of simvastatin and cholestyramine on lipoprotein profile in hyperlipidaemia of nephrotic syndrome.

Authors:  A J Rabelink; R J Hené; D W Erkelens; J A Joles; H A Koomans
Journal:  Lancet       Date:  1988-12-10       Impact factor: 79.321

Review 2.  High-density lipoprotein--the clinical implications of recent studies.

Authors:  D J Gordon; B M Rifkind
Journal:  N Engl J Med       Date:  1989-11-09       Impact factor: 91.245

Review 3.  Borderline hypercholesterolaemia: when to introduce drugs.

Authors:  D Bhatnagar; P N Durrington
Journal:  Postgrad Med J       Date:  1989-08       Impact factor: 2.401

4.  Strategies for reducing coronary heart disease and desirable limits for blood lipid concentrations: guidelines of the British Hyperlipidaemia Association.

Authors:  J Shepherd; D J Betteridge; P Durrington; M Laker; B Lewis; J Mann; J P Miller; J P Reckless; G R Thompson
Journal:  Br Med J (Clin Res Ed)       Date:  1987-11-14

5.  Proteinuria: value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus.

Authors:  K Borch-Johnsen; S Kreiner
Journal:  Br Med J (Clin Res Ed)       Date:  1987-06-27

6.  Effects of fish oil supplementation on glucose and lipid metabolism in NIDDM.

Authors:  M Borkman; D J Chisholm; S M Furler; L H Storlien; E W Kraegen; L A Simons; C N Chesterman
Journal:  Diabetes       Date:  1989-10       Impact factor: 9.461

7.  Comparison of a high-carbohydrate diet with a high-monounsaturated-fat diet in patients with non-insulin-dependent diabetes mellitus.

Authors:  A Garg; A Bonanome; S M Grundy; Z J Zhang; R H Unger
Journal:  N Engl J Med       Date:  1988-09-29       Impact factor: 91.245

8.  Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study.

Authors:  A Fontbonne; E Eschwège; F Cambien; J L Richard; P Ducimetière; N Thibult; J M Warnet; J R Claude; G E Rosselin
Journal:  Diabetologia       Date:  1989-05       Impact factor: 10.122

9.  Reduction of mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by combined treatment with clofibrate and nicotinic acid.

Authors:  L A Carlson; G Rosenhamer
Journal:  Acta Med Scand       Date:  1988

10.  Long-term treatment of hypercholesterolemic non-insulin dependent diabetics (NIDDM) with pravastatin (CS-514).

Authors:  G Yoshino; T Kazumi; M Iwai; M Matsushita; K Matsuba; R Uenoyama; I Iwatani; S Baba
Journal:  Atherosclerosis       Date:  1989-01       Impact factor: 5.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.